Format

Send to

Choose Destination
Eur Neuropsychopharmacol. 2015 Dec;25(12):2318-25. doi: 10.1016/j.euroneuro.2015.08.019. Epub 2015 Sep 7.

A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature.

Author information

1
Department of Psychiatry, Sheba Medical Center, and Sackler School of Medicine, Tel Aviv University , Tel Hashomer, Israel. Electronic address: jzohar@post.tau.ac.il.
2
Department of Psychiatry, University of California, San Diego, USA.
3
Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich, Germany.
4
Department of Psychiatry and Cellular & Molecular Medicine, University of Ottawa, Canada K1Z 7K4.
5
Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
6
Department of Psychiatry and Neurosciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
7
Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
8
Spedding Research Solutions SARL, 6 Rue Ampere, Le Vesinet 78110, France.
9
University Department, Warneford Hospital, Oxford OX3 7JX , UK.
10
Centre for Neuropsychopharmacology Division of Brain Sciences Imperial College, London, UK.

Abstract

Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.

KEYWORDS:

Adherence; Mode of action; Neuroscience; Nomenclature; Pharmacological domain; Psychotropic drugs

PMID:
26527055
DOI:
10.1016/j.euroneuro.2015.08.019
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center